In the secondary BM transplantation (BMT), no mice injected with STAP-1 KO GFP+ cells developed CML, while 36.7% of the mice transplanted with GFP+ cells derived from WT mice developed leukemia within 28 days. The gene discussed is STAP1; the disease is leukemia.